Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | MCARH125 |
Trade Name | |
Synonyms | MCARH-125|MCARH 125 |
Drug Descriptions |
MCARH125 are autologous T-cells engineered to express a chimeric antigen receptor (CAR) that targets the B-cell maturation antigen (BCMA; TNFRSF17), which potentially induce cytotoxicity in tumor cells expressing BCMA (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C188226 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
MCARH109 + MCARH125 | MCARH109 MCARH125 | 0 | 1 |
MCARH125 | MCARH125 | 0 | 0 |